These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 39106789)
1. Acute necrotizing encephalopathy infected with the SARS-CoV-2 in children: Case series and literature review of clinical outcomes with the use of Tocilizumab. Ma Y; Liu L; Chen F; Zhan W; Li M; Su Y Eur J Paediatr Neurol; 2024 Sep; 52():67-75. PubMed ID: 39106789 [TBL] [Abstract][Full Text] [Related]
2. [Primary observational study of tocilizumab in children with severe acute necrotizing encephalopathy]. Zhou YP; Chen WM; Zhu XD; Jiang Q; Cui Y; Wang CX; Ren YQ; Lu GP; Zhang YC Zhonghua Er Ke Za Zhi; 2024 Aug; 62(8):764-769. PubMed ID: 39039879 [No Abstract] [Full Text] [Related]
3. [Clinical and imaging analysis of neurological complications in critically ill children infected with SARS-CoV-2 Omicron]. Wang X; Qi X; Zhao Y; Wei F; Yang W; Zeng H Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Nov; 35(11):1157-1163. PubMed ID: 37987125 [TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and short-term prognosis of 22 cases with SARS-CoV-2 infection associated acute encephalopathy]. Ren CH; Yang XY; Liu ZM; Zhuo XW; Han XD; Dai LF; Tian XJ; Feng WX; Ge L; Han TL; Chen CH; Fang F Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):543-549. PubMed ID: 37312467 [No Abstract] [Full Text] [Related]
5. Clinical characteristics of 4,520 paediatric patients infected with the SARS-CoV-2 omicron variant, in Xi'an, China. Yue J; Cao J; Liu L; Yin L; Li M Front Pediatr; 2024; 12():1325562. PubMed ID: 38464898 [TBL] [Abstract][Full Text] [Related]
6. Acute necrotizing encephalopathy in children with COVID-19: a retrospective study of 12 cases. Lin X; Wang Y; Li X; Abdalla M; Zhang F; Dong C; Lu W; Liu X; Zhang J; Ma K; Ma X; Jiang Q Front Neurol; 2023; 14():1184864. PubMed ID: 37602239 [TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognosis in 12 children with SARS-CoV-2 Omicron variant infection-associated acute necrotizing encephalopathy]. Shen JM; Liu RH; Li ZP; Dong JH; Tong JN; Li J Zhongguo Dang Dai Er Ke Za Zhi; 2023 Nov; 25(11):1170-1174. PubMed ID: 37990463 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and imaging manifestations of acute necrotizing encephalopathy in children. Wu L; Peng H; Jiang Y; He L; Jiang L; Hu Y Int J Dev Neurosci; 2022 Aug; 82(5):447-457. PubMed ID: 35688614 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-Related Acute Necrotizing Encephalopathy of Childhood With Good Response to Tocilizumab in an Adolescent. Ho JHY; Lee CYM; Chiong YK; Aoyama R; Fan LJ; Tan AHS; Han VX Pediatr Neurol; 2023 Feb; 139():65-69. PubMed ID: 36529001 [TBL] [Abstract][Full Text] [Related]
10. Defining the Clinicoradiologic Syndrome of SARS-CoV-2 Acute Necrotizing Encephalopathy: A Systematic Review and 3 New Pediatric Cases. Lee VW; Kam KQ; Mohamed AR; Musa H; Anandakrishnan P; Shen Q; Palazzo AF; Dale RC; Lim M; Thomas T Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):e200186. PubMed ID: 38086061 [TBL] [Abstract][Full Text] [Related]
11. Acute necrotizing encephalopathy in adult patients with influenza: a case report and review of the literature. Chen H; Lan SC; Tseng YL; Chang YY; Lu YT; Lan MY BMC Infect Dis; 2024 Sep; 24(1):931. PubMed ID: 39251995 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement. Pongpitakmetha T; Hemachudha P; Rattanawong W; Thanapornsangsuth P; Viswanathan A; Hemachudha T BMC Infect Dis; 2022 Jul; 22(1):640. PubMed ID: 35870896 [TBL] [Abstract][Full Text] [Related]
13. Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy in Children: A Retrospective Single-Center Study. Song Y; Li S; Xiao W; Shen J; Ma W; Wang Q; Yang H; Liu G; Hong Y; Li P; Yang S Med Sci Monit; 2021 Jan; 27():e928374. PubMed ID: 33388740 [TBL] [Abstract][Full Text] [Related]
14. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327 [TBL] [Abstract][Full Text] [Related]
15. Tocilizumab in acute necrotizing encephalopathy (ANE): How much, how soon, and will it improve outcomes beyond survival? Han VX; Lim M Eur J Paediatr Neurol; 2024 Sep; 52():A3-A4. PubMed ID: 39244415 [No Abstract] [Full Text] [Related]
16. Clinical evaluation of acute necrotizing encephalopathy in children. Fan X; Huang L; Li S; Yang S; Song Y; Chen Q; Xiong Y; Peng Q; Ma W; Hu D; Li P Front Pediatr; 2022; 10():947693. PubMed ID: 36090552 [TBL] [Abstract][Full Text] [Related]
17. Acute Necrotizing Encephalopathy in Adult Patients With COVID-19: A Systematic Review of Case Reports and Case Series. Karami S; Khalaj F; Sotoudeh H; Tajabadi Z; Shahidi R; Habibi MA; Sattari MS; Azimi A; Forouzannia SA; Rafiei R; Reihani H; Nemati R; Teimori S; Khalaji A; Sarmadi V; Dadjou A J Clin Neurol; 2023 Nov; 19(6):597-611. PubMed ID: 37455513 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review. Antwi-Amoabeng D; Kanji Z; Ford B; Beutler BD; Riddle MS; Siddiqui F J Med Virol; 2020 Nov; 92(11):2516-2522. PubMed ID: 32436994 [TBL] [Abstract][Full Text] [Related]
19. Ferritin as an Effective Predictor of Neurological Outcomes in Children With Acute Necrotizing Encephalopathy. Lee EP; Lin JJ; Chang HP; Yen CW; Hsieh MS; Chan OW; Lin KL; Su YT; Mu CT; Hsia SH Pediatr Neurol; 2024 Mar; 152():162-168. PubMed ID: 38295717 [TBL] [Abstract][Full Text] [Related]
20. Malaysian outcome of acute necrotising encephalopathy of childhood. Fong CY; Saw MT; Li L; Lim WK; Ong LC; Gan CS Brain Dev; 2021 Apr; 43(4):538-547. PubMed ID: 33358123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]